FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

An FDA advisory committee voted on Thursday to include the popular peptide BPC-157 on a drug compounding list. This decision, as reported by Reuters and other sources, means the panel has officially voted to place the specific peptide BPC-157 on the compounding list. The action taken by the FDA panel ensures that BPC-157 is now recognized within the framework of the drug compounding list following the committee's recent voting process on Thursday.